170888 ⎘
Detection or diagnosis of diseases; Pediatrics Congenital anomalies
Sub-classes:PREPARATION OF FETAL NUCLEATED RED BLOOD CELLS (NRBCS) FOR DIAGNOSTIC TESTING
#2BIOMARKERS FOR CEREBRAL METABOLIC DISORDERS, AND DIAGNOSTIC METHODS USING THEREOF
#3System and Method for Expression Amounts of DNA Sequences in a Biological Sample
#4PLACENTAL PROTEIN BIOMARKERS FOR GESTATIONAL AGE ASSESSMENT AND RELATED METHODS
#5BIOSENSOR IMPLEMENTING FP-WA COUPLING MODE, PREPARATION METHOD THEREFOR, AND USE THEREOF
#6PREPARATION OF FETAL NUCLEATED RED BLOOD CELLS (NRBCs) FOR DIAGNOSTIC TESTING
#7antiRPS4Y1 mAb
#8Preparation of fetal nucleated red blood cells (NRBCs) for diagnostic testing
#9DETERMINATION OF FETAL GENOTYPE USING MATERNAL BIOLOGICAL SAMPLE
#10Methods For The Diagnosis Of Fetal Abnormalities
#11METHODS FOR SCREENING CEREBLON MODIFYING COMPOUNDS
#12Biomarker panel for non-invasive diagnosis of congenital renal dysfunction
#13USE OF AMNIOTIC FLUID PEPTIDES FOR PREDICTING POSTNATAL RENAL FUNCTION IN CONGENITAL ANOMALIES OF THE KIDNEY AND THE URINARY TRACT
#14Use of Lyso-GB1 as Druggable Target
#15COMPOSITION FOR PREVENTING OR TREATING CARDIOFACIOCUTANEOUS SYNDROME
#16Placental protein biomarkers for gestational age assessment and related methods
#17Processes and Compositions for Methylation-Based Enrichment of Fetal Nucleic Acid From a Maternal Sample Useful for Non-Invasive Prenatal Diagnoses
#18Methods for the diagnosis of fetal abnormalities
#19METHODS AND DEVICES FOR SEQUENCING
#20SYSTEMS AND METHODS FOR SAMPLE PREPARATION
#21Systems and methods for enhanced SCODA
#22Composition for preventing or treating cardiofaciocutaneous syndrome
#23Methods for screening cereblon modifying compounds
#24Use of lyso-Gb1 as druggable target
#25Devices and methods for determining and/or isolating cells such as circulating cancer or fetal cells
#26METHOD OF ANALYSING A BLOOD SAMPLE OF A SUBJECT FOR THE PRESENCE OF A FOETAL DISEASE OR CONDITION MARKER
#27Purification, extraction and analyses of fetal neurally-derived exosomes in maternal blood and neonatal neurally-derived exosomes from neonatal blood
#28Methods for the diagnosis of fetal abnormalities
#29PREPARATION OF FETAL NUCLEATED RED BLOOD CELLS (NRBCs) FOR DIAGNOSTIC TESTING
#30TREATMENT OF HUTCHINSON-GILFORD PROGERIA SYNDROME AND DISEASES RELATED TO VASCULAR AGEING
#31MEANS AND METHODS FOR NON-INVASIVE DIAGNOSIS OF CHROMOSOMAL ANEUPLOIDY
#32Metabolomic prediction of congenital heart defect during pregnancy, newborn and pediatric stages
#33NON-INVASIVE DIAGNOSTIC METHOD FOR THE EARLY DETECTION OF FETAL MALFORMATIONS
#34INDUCED PLURIPOTENT STEM CELL MODEL OF NOONAN SYNDROME AND USE THEREOF
#35Systems and methods for enhanced SCODA
#36Non invasive method for prenatal diagnosis
#37Methods for the diagnosis of fetal abnormalities
#38Analysis of a panel of cerebrotendinous xanthomatosis biomarkers using site specific derivation and LC/MS/MS workflow
#39Method of diagnosing galactosemia in neonatal screening
#40Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
#41METHOD OF IDENTIFYING FOETAL ERYTHROBLAST
#42Compositions and Methods of Detecting and Treating Neural Tube Defects
#43Methods of detecting aneuploidy in human embryos
#44Solid support and method of enhancing the recovery of biological material therefrom
#45Systems and methods for enhanced SCODA
#46Diagnosis of hereditary spastic paraplegias (HSP) by identification of a mutation in the ZFYVE26 gene or protein
#47METHODS FOR DETERMINING A GENE EXPRESSION PROFILE AND FOR DISEASE DIAGNOSIS
#48Means and methods for non-invasive diagnosis of chromosomal aneuploidy
#49Variants of C-type natriuretic peptide
#50Pharmaceutical compositions containing protease and methods for the treatment of lysosomal storage diseases
#51EMBRYO QUALITY ASSESSMENT BASED ON BLASTOMERE DIVISION AND MOVEMENT
#52Systems and methods for enhanced SCODA
#53Biomarkers for the detection and screening of down syndrome
#54COMPOSITIONS AND METHODS FOR THE TREATMENT OR PREVENTION OF MITOCHONDRIAL DISEASES
#55PROCESSES AND COMPOSITIONS FOR METHYLATION-BASED ENRICHMENT OF FETAL NUCLEIC ACID FROM A MATERNAL SAMPLE USEFUL FOR NON-INVASIVE PRENATAL DIAGNOSES
#56In Vitro Model Of Spinal Muscular Atrophy
#57Methods For The Diagnosis Of Fetal Abnormalities
#58Adam12, A Novel Marker For Abnormal Cell Function
#59Method for Detecting and Quantitating Multiple-Subcellular Components
#60Methods for the diagnosis of fetal disease
#61MEASURING LEVELS OF FRATAXIN
#62DIAGNOSIS OF HEREDITARY SPASTIC PARAPLEGIAS (HSP) BY IDENTIFICATION OF A MUTATION IN THE ZFYVE26 GENE OR PROTEIN
#63MESP1 AS A MASTER REGULATOR OF MULTIPOTENT CARDIOVASCULAR PROGENITOR SPECIFICATION AND USES THEREOF
#64Variants of C-type natriuretic peptide
#65In vitro model of spinal muscular atrophy
#66METHOD OF SURFACE PLASMON RESONANCE (SPR) TECHNOLOGY TO DETECT GENOMIC DISORDERS FOR PRENATAL DIAGNOSIS
#67Methods and compositions for multiplexed screening of disease
#68ADAM12, a novel marker for abnormal cell function
#69Detection of oligosaccharides
#70METHODS INVOLVING LEF-1 REGULATION AND USE OF LEF-1 OR COMPOUNDS ALTERING LEF-1 SIGNALLING FOR TREATING OR PREVENTING DISEASES
#71Processes and compositions for methylation-based acid enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
#72EMBRYO QUALITY ASSESSMENT BASED ON BLASTOMERE DIVISION AND MOVEMENT
#73Early Diagnosis of Congenital Abnormalities in the Offspring of Diabetic Mothers
#74METHOD FOR DETECTING AND QUANTITATING MULTIPLE SUBCELLULAR COMPONENTS
#75Marker for Chromosomal Abnormalities
#76DNA encoding polypeptide capable of modulating muscle-specific tyrosine kinase activity
#77Formation and rejuvenation of organs and alcohol damaged organ regeneration through stem cell nutrients
#78ANTIBODY AGAINST A PEPTIDE DERIVED FROM HUMAN MUTANT LAMIN A PROTEIN AND USES THEREOF
#79Method for Detecting and Quantitating Multiple-Subcellular Components
#80METHOD FOR DETECTING AND QUANTITATING MULTIPLE-SUBCELLULAR COMPONENTS
#81Methods for the diagnosis of fetal abnormalities
#82ANALYSIS OF RARE CELL-ENRICHED SAMPLES
#83RARE CELL ANALYSIS USING SAMPLE SPLITTING AND DNA TAGS
#84ADAM12, a novel marker for abnormal cell function
#85Diagnosis of fetal aneuploidy
#86Method for detecting and quantitating multiple subcellular components